Renovaro Inc

자세한 내용은 Renovaro Inc 회사

Renovaro Inc. specializes in cancer diagnostics and therapeutics powered by artificial intelligence (AI). The Company operates through two subsidiaries: Renovaro Biosciences, Inc. (Renovaro Biosciences) and Renovaro Cube. Renovaro Biosciences is a biotechnology company intending to develop advanced allogeneic cell and gene therapies to promote stronger immune system responses potentially for long-term or life-long cancer remission in some of the deadliest cancers, and potentially to treat or cure serious infectious diseases such as Human Immunodeficiency Virus (HIV) infections. Renovaro Cube is an AI-driven healthcare technology company focusing on the earliest possible detection of cancer and its recurrence. Renovaro Cube has developed an AI platform that analyzes genetics using Explainable AI to provide earlier and more accurate cancer diagnosis. This platform uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients.

회사 정보

종목 코드 RENB

회사 이름Renovaro Inc

상장일Nov 18, 2014

CEOMr. David Weinstein

직원 수25

유형Ordinary Share

회계 연도 종료Nov 18

주소2080 Century Park East,

도시LOS ANGELES

증권 거래소NASDAQ Capital Market Consolidated

국가United States of America

우편 번호90067

전화14539179840

웹사이트https://renovarobio.com/

종목 코드 RENB

상장일Nov 18, 2014

CEOMr. David Weinstein

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Maurice Van Tilburg

Independent Chairman of the Board

--

Mr. Chris Tyson

Executive Vice President

--

Mr. David Weinstein

Chief Executive Officer, Director

--

Mr. Nathen Fuentes, CPA

Chief Financial Officer

--

Mr. Douglas W. Calder

Independent Director

--

Mr. Mark Anthony Collins, Ph.D.

Independent Director

--

Mr. James A. Mcnulty, CPA

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Maurice Van Tilburg

Independent Chairman of the Board

--

Mr. Chris Tyson

Executive Vice President

--

Mr. David Weinstein

Chief Executive Officer, Director

--

Mr. Nathen Fuentes, CPA

Chief Financial Officer

--

Mr. Douglas W. Calder

Independent Director

--

Mr. Mark Anthony Collins, Ph.D.

Independent Director

--

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Sat, Aug 2

주주

주주 유형

주주

비율

PasecoApS

11.69%

RS Group ApS

7.29%

Gumrukcu (Serhat)

5.42%

BlackRock Institutional Trust Company, N.A.

2.95%

The Vanguard Group, Inc.

2.45%

Other

70.20%

주주

비율

PasecoApS

11.69%

RS Group ApS

7.29%

Gumrukcu (Serhat)

5.42%

BlackRock Institutional Trust Company, N.A.

2.95%

The Vanguard Group, Inc.

2.45%

Other

70.20%

주주 유형

주주

비율

Corporation

36.84%

Individual Investor

10.44%

Investment Advisor

8.61%

Investment Advisor/Hedge Fund

3.55%

Research Firm

0.41%

Hedge Fund

0.13%

Bank and Trust

0.07%

Pension Fund

0.04%

Other

39.92%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

157

103.42M

47.15%

+42.61M

2025Q1

161

103.48M

60.94%

+42.30M

2024Q4

155

103.71M

63.86%

+49.62M

2024Q3

149

51.49M

35.21%

-1.80M

2024Q2

151

51.88M

36.43%

+6.39M

2024Q1

154

44.98M

32.23%

+3.81M

2023Q4

151

44.01M

67.51%

+217.77K

2023Q3

146

41.12M

71.08%

+1.11M

2023Q2

147

41.48M

71.99%

+3.87M

2023Q1

143

36.45M

65.90%

-482.82K

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

PasecoApS

12.62M

7.33%

+8.16M

+182.78%

Oct 17, 2024

RS Group ApS

13.60M

7.9%

+468.70K

+3.57%

Oct 17, 2024

Gumrukcu (Serhat)

12.53M

7.28%

--

Apr 10, 2025

BlackRock Institutional Trust Company, N.A.

6.81M

3.96%

+847.01K

+14.20%

Mar 31, 2025

The Vanguard Group, Inc.

5.66M

3.29%

-58.46K

-1.02%

Mar 31, 2025

William (Anderson Wittekind)

4.77M

2.77%

--

Apr 10, 2025

Geode Capital Management, L.L.C.

2.37M

1.38%

+35.02K

+1.50%

Mar 31, 2025

State Street Global Advisors (US)

2.00M

1.16%

-61.67K

-2.99%

Mar 31, 2025

Weinstein (David Hershel)

250.00K

0.15%

+250.00K

--

Oct 17, 2024

Weird Science LLC

840.32K

0.49%

--

Apr 10, 2025

0.261USD

Renovaro Inc

0.261

개요

회사

금융